This review examines the safety and implications of testosterone therapy (TT) in men with a history of prostate cancer, a population historically advised against TT due to concerns about cancer recurrence. Emerging evidence suggests that TT may be safe for select prostate cancer survivors, particularly those with low-risk disease and
